Blackwell signs on with Sudler & Hennessey

Share this article:
Sudler & Hennessey has hired multicultural marketing guru Daria Blackwell to serve in the newly created role of director of the agency’s S&H Multicultural unit. Blackwell will work with Ruben Gutierrez, managing director of S&H’s IntraMed unit, to develop professional and patient materials focusing on the patient/physician interface in the multicultural environment, she told MM&M. “We think that by focusing on the interaction the physician and the patient perspective, we can really change the way the outcomes in certain conditions,” she said. Blackwell joined S&H less than a month ago. She has spent the past five years as a healthcare consultant to agencies and pharma companies. In 2004, Blackwell was named president of the Healthcare Businesswoman’s Association, where she remains active as a member of the board of directors. From 1999 to 2001 she was president of Bozell Global Healthcare.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...